Presiding arbitrator engagement in international pharma case
Mr. Goldstein has been engaged since November 2014 as presiding arbitrator of a three-member tribunal hearing an international pharmaceutical contract dispute under the Rules of Arbitration of the International Chamber of Commerce (ICC). Mr. Goldstein has experience both as arbitrator and as counsel in the international pharmaceutical sector. In August 2014 he completed an extended engagement as arbitration counsel to a U.S. pharma developer in a dispute with an Asian partner, completing a mediated settlement that preceded merits hearing and followed submission of extensive expert reports evaluating the market for a drug marketed in the US but still under development in the Asian market.